Newsroom
Sorted by: Latest
-
RAFTR Roofing + Exteriors Appoints Denis Gaynor as Chief Marketing Officer to Lead Multi-State Growth Strategy
ATLANTA--(BUSINESS WIRE)--RAFTR Roofing + Exteriors (RAFTRx), a leading provider of roofing and storm restoration services across 16 states, 36 markets, and 9 brands, is proud to announce the appointment of Denis Gaynor as its new Chief Marketing Officer (CMO). With over 20 years of consumer marketing leadership experience in the digital and home services sectors, including key roles at Microsoft, Amazon, and Renovo, Gaynor brings deep expertise in scaling marketing teams and accelerating custo...
-
Investment Opportunities in the Global Grow Tents Market, 2026-2032 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Grow Tents Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Grow Tents Market is experiencing a notable trajectory of growth, expanding from USD 797.74 million in 2025 to USD 859.31 million in 2026, with projections estimating it will reach USD 1.27 billion by 2032. This dynamic growth can be attributed to several evolving operational, technological, and commercial drivers in modern controlled-environment agriculture. As...
-
Prudent AI Introduces Industry's First Universal Income Platform
DOVER, Del.--(BUSINESS WIRE)--Prudent AI launched Prudent AI Upfront Income, the first universal income platform that calculates qualified income with day-one certainty....
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 1/19/2026 Issue ¦ Yorkshire Water Services Finance Plc GBP 125,000,000 1.46% RPI Linked due 01 Aug 2056 ISIN Number ¦ XS0275222114 ISIN Reference ¦ 27522211 Issue Nomin GBP ¦ 125000000 Period ¦ 8/1/2025 to 2/1/2026 Payment Date 2/2/2026 Number of Days ¦ 184 Rate ¦ 2.967275 Denomination GBP ¦ 50000 ¦ 125000000 ¦ Amount Payable per Denomination ¦ 741.82 ¦ 1854546.75 ¦ Bank...
-
New Jersey Resources Board of Directors Declares Quarterly Dividend
WALL, N.J.--(BUSINESS WIRE)--The board of directors (the “Board”) of New Jersey Resources Corporation (NYSE: NJR) unanimously declared a quarterly dividend on its common stock of $0.475 per share. The dividend will be payable on April 1, 2026, to shareowners of record as of March 11, 2026. NJR has paid quarterly dividends continuously since its inception in 1952, and has raised the dividend every year for the last 30 years. About New Jersey Resources New Jersey Resources (NYSE: NJR) is a Fortun...
-
Mauna Kea Technologies Announces Its 2026 Financial Calendar Highlighted by Its Participation in Several Investor Forums
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces its financial calendar for the 2026 fiscal year as well as the resumption of its participation in investor conferences. Events Date 2025 Annual Results April 9, 2026 Q1 2026 Sales April 16, 2026 2026 Annual General Meeting June 4, 2026 Q2 2026 Sales July 21, 2026 20...
-
Mauna Kea Technologies annonce son agenda financier 2026 marqué par sa participation à de nombreux forums investisseurs
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth : ALMKT) (la « Société ») inventeur de Cellvizio®, la plateforme multidisciplinaire d'endomicroscopie confocale laser par minisonde et par aiguille (p/nCLE), annonce son calendrier financier pour l’exercice 2026 ainsi que la reprise de sa participation aux conférences investisseurs. Événements Date Résultats annuels 2025 9 avril 2026 Chiffre d’affaires T1 2026 16 avril 2026 Assemblée générale ordinaire 202...
-
INTENT Biologics Receives FDA Agreement Granting a Full Waiver for its Pediatric Study Plan for PEP Biologic™ in Advanced Wound Care
ROCHESTER, Minn.--(BUSINESS WIRE)--INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the U.S. Food and Drug Administration (FDA) has agreed to INTENT’s Initial Pediatric Study Plan (iPSP) for PEP Biologic™ under IND 019567, supporting the company’s request for a full pediatric waiver for its forthcoming Biologics License Applicati...
-
Floating Hotels Market Worth Over $8 Billion by 2032: Industry & Competition Analysis Featuring AmaWaterways, CroisiEurope, Floatel International, OHT, Semco Maritime, Viking River Cruises & More - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Floating Hotels Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Floating Hotels Market, valued at USD 4.83 billion in 2025, is projected to grow to USD 5.19 billion in 2026 and further expand to USD 8.03 billion by 2032, reflecting a steady CAGR of 7.50%. Positioned at the intersection of maritime engineering and hospitality innovation, floating hotels offer a unique proposition by integrating advanced vessel architectur...
-
Kardium Announces Publication of PULSAR Pivotal Trial Results in JACC
VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium Inc., an emerging leader in advanced solutions for atrial fibrillation, is proud to announce the publication of the PULSAR clinical trial results in the Journal of the American College of Cardiology (JACC). This landmark study evaluated the Globe® Pulsed Field System by Kardium for the treatment of paroxysmal atrial fibrillation (PAF). The multicenter pivotal trial demonstrated that the Globe System achieved durable pulmonary vein isolation...